|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 25 MASSACHUSETTS AVENUE, NW |
Address2 | SUITE 600 |
City | WASHINGTON |
State | DC |
Zip Code | 20001-7400 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Chicago |
State | IL |
Zip Code | 60611-5885 |
Country | USA |
|
5. Senate ID# 2877-12
|
||||||||
|
6. House ID# 304640000
|
TYPE OF REPORT | 8. Year | 2023 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: George E. Cox III, JD |
Date | 10/20/2023 10:14:53 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R. 766, Preventive Health Savings Act, all provisions
S. 114, Preventive Health Savings Act, all provisions
Reauthorization of the Pandemic and All-Hazards Preparedness Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Katherine |
Dapper |
|
|
|
Chase |
Thomas |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
H.R. 2389, Resident Physician Shortage Reduction Act of 2023, all provisions
S. 1302, Resident Physician Shortage Reduction Act of 2023, all provisions
H.R. 751, Fair Access In Residency (FAIR) Act, all provisions
H.R. 1202, Resident Education Deferred Interest (REDI) Act, all provisions
S. 704, Resident Education Deferred Interest (REDI) Act, all provisions
H.R. 2761, Specialty Physicians Advancing Rural Care (SPARC) Act, all provisions
S. 705, Specialty Physicians Advancing Rural Care (SPARC) Act, all provisions
H.R. 3046, Medical Student Education Authorization Act of 2023, all provisions
S. 1403, Medical Student Education Authorization Act of 2023, all provisions
H.R. 5388, Supporting Innovation for Seniors Act, all provisions
Medicare Student Education Authorization Act/draft
Substance Use Disorder Workforce Act/draft
Opioid Workforce Act/reintroduction
Indian Health Service Health Professions Tax Fairness Act/draft
Pathways to Practice
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Katherine |
Dapper |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
George |
Cox |
III |
|
|
Alexis |
Pierce |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 618, Improving Access to Workers Compensation for Injured Federal Workers Act, all provisions
S. 131, Improving Access to Workers Compensation for Injured Federal Workers Act, all provisions
S. 127, Pharmacy Benefit Manager Transparency Act of 2023, all provisions
S. 2362, Drug Shortage Prevention Act of 2023, all provisions
H.R. 4534, Women and Lung Cancer Research and Preventive Services Act of 2023, all provisions
S. 2245, Women and Lung Cancer Research and Preventive Services Act of 2023, all provisions
H.R. 1631, Protecting and Enhancing Public Access to (PRO) Codes Act, all provisions
S. 835, Protecting and Enhancing Public Access to (PRO) Codes Act, all provisions
H.R. 5687, HSA Modernization Act of 2023, all provisions
H.R. 1359, Modernizing Opioid Treatment Access Act, all provisions
S. 644, Modernizing Opioid Treatment Access Act, all provisions
H.R. 2630, Safe Step Act, all provisions
S. 652, Safe Step Act, all provisions
H.R. 3432, Telemental Health Care Access Act of 2023, all provisions
H.R. 2923, Living Donor Protection Act of 2023, all provisions
S. 1384, Living Donor Protection Act of 2023, all provisions
H.R. 3752, Living Donor Protection Act of 2023, all provisions
S. 2840, Bipartisan Primary Care and Health Workforce Act, all provisions
H.R. 3838, Preventing Maternal Deaths Reauthorization Act of 2023, all provisions
S. 2415, Preventing Maternal Deaths Reauthorization Act of 2023, all provisions
H.R. 382, Pandemic is Over Act, all provisions
H.R. 467, Halt All Lethal Trafficking of (HALT) Fentanyl Act, all provisions
H.R. 3065, School Access to Naloxone Act of 2023, all provisions
Reauthorization of the Pandemic and All-Hazards Preparedness Act
Federal Employee Drug Savings Act/draft
Practice ownership transparency
Telehealth/prescribing controlled substances
Generic sterile injectable drugs/supply chain and payment issues
Abortion/Methotrexate supply chain issues
Augmented Intelligence
Maternal Health/morbidity and mortality crisis
Reproductive health/over the counter birth control
Street medicine programs
Nutrition policy
Interoperability and data sharing
Cybersecurity tools
Prior authorization and utilization management reform
Prior authorization/voluntary insurer actions
Telehealth flexibility/permanent expansion
Health Equity
Gender affirming care
Pharmacy Benefit Managers (PBM)
Data privacy
HIPAA/electronic health records
Health breach notification
Patient education opportunities
National Physician Suicide Awareness Day
Digital Health/AI principles
Clinical Algorithms/Bias/discrimination
Current Procedural Terminology
Mental health/physician burnout
Open Access
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Drug Enforcement Administration (DEA), White House Office, Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Federal Trade Commission (FTC), Natl Institutes of Health (NIH), Agency for Healthcare Research & Quality (AHRQ)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Katherine |
Dapper |
|
|
|
Dana |
Lichtenberg |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Jeffrey |
Coughlin |
|
|
|
Shannon |
Curtis |
|
|
|
Jennifer |
Hananoki |
|
|
|
Suzanne |
Joy |
|
|
|
Sandy |
Marks |
|
|
|
Matthew |
Reid |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
|
Ashley |
Delosh |
|
|
|
Lisa |
Myers |
|
|
|
Alexis |
Pierce |
|
|
|
Jennifer |
Brown |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
H.R. 4942, Conrad State 30 and Physician Access Reauthorization Act, all provisions
S. 665, Conrad State 30 and Physician Access Reauthorization Act, all provisions
H.R. 4875, Doctors in our Borders Act, all provisions
S. 2719, Directing Our Countrys Transfer Of Residency Slots (DOCTORS) Act, all provisions
H.R. 5525, Continuing Appropriations and Border Security Enhancement Act, 2024, all provisions
Healthcare Workforce Resilience Act/reintroduction
Conrad 30 waiver
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Homeland Security - Dept of (DHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Katherine |
Dapper |
|
|
|
Dana |
Lichtenberg |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Alexis |
Pierce |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
S. 113, Prescription Pricing for the People Act of 2023, all provisions
H.R. 3752, Living Donor Protection Act of 2023, all provisions
Physician practice ownership
Insurance market competition
Health care transparency and competition
Health care market consolidation
PBM commercial markets/competition and vertical integration
Antitrust
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Federal Trade Commission (FTC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Katherine |
Dapper |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
George |
Cox |
III |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 2474, Strengthening Medicare for Patients and Providers Act, all provisions
H.R. 4822, Health Care Price Transparency Act of 2023, all provisions
H.R. 4507, Transparency in Coverage Act of 2023, all provisions
H.R. 4508, Hidden Fee Disclosure Act, all provisions
H.R. 3284, Providers and Payers COMPETE Act, all provisions
H.R. 4828, Imaging Services Price Transparency Act of 2023, all provisions
H.R. 4882, Clinical Laboratory Price Transparency Act of 2023, all provisions
H.R. 4839, Hospital and ASC Price Transparency Act of 2023, Section 101
H.R. 5378, Lower Costs, More Transparency Act, all provisions
H.R. 5013, Value in Health Care Act of 2023, all provisions
H.R. 2389, Resident Physician Shortage Reduction Act of 2023, all provisions
S. 1302, Resident Physician Shortage Reduction Act of 2023, all provisions
H.R. 751, Fair Access In Residency (FAIR) Act, all provisions
H.R. 977, Patient Access to Higher Quality Health Care Act of 2023, all provisions
S. 470, Patient Access to Higher Quality Health Care Act of 2023, all provisions
H.R. 4189, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2023, provisions relating to telehealth
S. 2016, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2023, provisions relating to telehealth
H.R. 1745, Medicare Fraud Detection and Deterrence Act of 2023, all provisions
H.R. 1746, Preventing Medicare Telefraud Act, all provisions
H.R. 2713, Improving Care and Access to Nurses (ICAN) Act, all provisions
S. 2418, Improving Care and Access to Nurses (ICAN) Act, all provisions
H.R. 1770, Equitable Community Access to Pharmacist Services Act, all provisions
S. 2477, Equitable Community Access to Pharmacist Services Act, all provisions
S. 1491, Pharmacy and Medically Underserved Areas Enhancement Act, all provisions
H.R. 1610, Chiropractic Medicare Coverage Modernization Act of 2023, all provisions
S. 799, Chiropractic Medicare Coverage Modernization Act of 2023, all provisions
S. 669, Increasing Mental Health Options Act of 2023, all provisions
H.R. 4968, Getting Over Lengthy Delays in Care As Required by Doctors (GOLD CARD) Act of 2023, provisions relating to prior authorization
S. 1246, Strengthening Medicare And Reducing Taxpayer (SMART) Prices Act, all provisions
H.R. 830, Help Ensure Lower Patient (HELP) Copays Act, all provisions
S. 1375, Help Ensure Lower Patient (HELP) Copays Act, all provisions
H.R. 5506, Hospitals As Naloxone Distribution Sites (HANDS) Act, all provisions
H.R. 5687, HSA Modernization Act of 2023, all provisions
H.R. 3046, Medical Student Education Authorization Act of 2023, all provisions
S. 1403, Medical Student Education Authorization Act of 2023, all provisions
H.R. 2829, Chronic Care Management Improvement Act of 2023, all provisions
H.R. 2377, Saving Access to Laboratory Services Act, all provisions
S. 1000, Saving Access to Laboratory Services Act, all provisions
H.R. 3432, Telemental Health Care Access Act of 2023, all provisions
S. 712, Connected MOM Act, all provisions
H.R. 4818, Treat and Reduce Obesity Act of 2023, all provisions
S. 2407, Treat and Reduce Obesity Act of 2023, all provisions
H.R. 977, Patient Access to Higher Quality Health Care Act of 2023, all provisions
H.R. 1694, Emergency Care Improvement Act, all provisions
H.R. 497, Freedom for Health Care Workers Act, all provisions
Improving Seniors Timely Access to Care Act of 2022/implementation
Opioid Workforce Act/reintroduction
Medicare Student Education Authorization Act/draft
Doctor Knows Best Act (House discussion draft, prior authorization)
Fewer Burdens for Better Care Act/discussion draft
Modernizing and Ensuring PBM Accountability (MEPA) Act/draft
Medicare program: No Surprises Act implementation
Medicare program: 21st Century Cure Act implementation
Medicare program: Budget neutrality
Medicare program: FY24 Medicare Physician Fee Schedule
Medicare program: Medicare Physician Payment Advisory Commission (MedPAC)/Physician payment system reform recommendations
Medicare program: Part B Medicare providers/MEI update
Medicare program: Merit-based Incentive Payment System (MIPS) Reforms/penalties
Medicare program: G2211 Inherent Complexity Code
Medicare program: Electronic direct deposits/unauthorized insurer fees
Medicare program: Making Care Primary (MCP)/alternative payment model (APM)
Medicare program: Medicare Part B/payment geographic disparities/primary care physicians
Medicare program: Physician Owned Hospitals
Medicare program: Site neutral payment policies
Medicare program: Breast reconstruction codes/reimbursement and coverage
Medicare program: MIPS/data feedback
Medicare program: MIPS hardship exceptions/payment penalties
Medicare program: MIPS Measure Development Process
Medicare program: Value-based payment models/comorbid conditions
Medicare program: Provider compliance/regulatory relief
Medicare program: Provider Enrollment, Chain, and Ownership System (PECOS) Enrollment/Revalidation
Medicare program: Open Payments
Medicare program: Diabetes
Medicare program: Scope of practice
Medicare program: Electronic Health Records (EHR) certification
Medicare program: Quality Payment Program/physician burdens
Medicare program: Health IT/physician burdens
Medicare program: HIPAA/electronic records
Medicare program: Interoperability/data sharing/information blocking
Medicare program: Data segmentation
Medicare program: Health care attachments/electronic transaction standards
Medicare program: Prior authorization reform
Medicare program: Episode-based Payment Model
Medicare program: Medicare Advantage cuts/Advanced Rate Notice
Medicare and Medicaid programs: Data/patient control
Medicare and Medicaid programs: Cybersecurity/Information blocking
Medicaid program: Medicaid unwinding
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Medicare Payment Advisory Commission (MedPAC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Katherine |
Dapper |
|
|
|
Dana |
Lichtenberg |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Jeffrey |
Coughlin |
|
|
|
Jennifer |
Hananoki |
|
|
|
Suzanne |
Joy |
|
|
|
Sandy |
Marks |
|
|
|
Matthew |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Ashley |
Delosh |
|
|
|
Bryan |
Hull |
|
|
|
Lisa |
Myers |
|
|
|
Alexis |
Pierce |
|
|
|
Jennifer |
Brown |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
H.R. 5687, HSA Modernization Act of 2023, all provisions
H.R. 5688, Bipartisan HSA Improvement Act of 2023, all provisions
Draft/Indian Health Service Health Professions Tax Fairness Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
H.R. 2819, Good Samaritan Health Professionals Act of 2023, all provisions
Healthcare Practitioner Disaster Protection Act/draft
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Christopher |
Sherin |
|
|
|
George |
Cox |
III |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
S. 10, VA Clinician Appreciation, Recruitment, Education, Expansion, and Retention Support (CAREERS) Act of 2023, all provisions
H.R. 3347, Protect Lifesaving Anesthesia Care for Veterans Act of 2023, all provisions
S. 2070, Protect Lifesaving Anesthesia Care for Veterans Act of 2023, all provisions
S. 2259, LINC VA Act, all provisions
VA Supremacy project
Scope of practice
Veterans Choice/Community Care Program
National Standards of Practice/Cytotechnologists and Histopathology Technologists
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Katherine |
Dapper |
|
|
|
Dana |
Lichtenberg |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
|
Alexis |
Pierce |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
TOB |
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |